AGP Executive Report

Industry Operations: DRM CEO Nic Bucholz will join an MJBizCon panel on cannabis facility design, covering planning, utilities and permitting for future builds. Retail Rules: Springfield is considering marijuana drive-thru sales until 1:30 a.m., while Crystal Lake has backed a second local drive-thru proposal. Massachusetts Question 8, meanwhile, could end recreational sales and home cultivation if voters approve it. Legal Scrutiny: Virginia Sen. Louise Lucas and six others face federal charges in an alleged cannabis trafficking and corruption scheme that includes claims of marijuana-license discussions with lawmakers. Market Shifts: A boom in cannabis drinks is widening a rift with the U.S. alcohol industry, as beverage makers compete for consumers. CBD Guidance: A new guide offers tips for reading CBD product labels and spotting marketing claims.

Virginia Cannabis Probe: Sen. L. Louise Lucas and six others were indicted over an alleged marijuana enterprise prosecutors say involved licensing talks and a $4.5 million scheme. The charges remain allegations, but the case puts political influence and cannabis-market oversight in focus. THC Drinks: Cannabis beverages are sharpening a fight with alcohol producers, who are pressing for tougher rules as more consumers turn to infused drinks. Market Structure: A Missouri study says the state may not need more marijuana business licenses, while questions remain about ownership concentration. Hemp Regulation: Hemp businesses received some relief after reports that they would not have to destroy stock under a federal ban.

Cannabis Drinks: THC beverages are fueling a high-stakes fight in the US alcohol industry, with brewers and distillers pushing for tighter rules as consumers seek alternatives to booze. Hemp and CBD Rules: Federal hemp restrictions threaten Michigan’s CBD businesses, while another report says hemp sellers may keep existing stock but won’t be able to sell it once the ban takes effect. UPS has also updated its hemp-shipping policy, adding another pressure point for the trade. Consumer Confidence: A new guide aims to help shoppers read CBD labels and avoid misleading marketing. Market Oversight: A Colorado audit found gaps in cannabis product-testing protections, while a Missouri study says the state may not need more marijuana business licenses but leaves questions about ownership concentration.

Hemp & CBD Rules: Upcoming federal hemp restrictions could leave businesses with stock they can no longer sell. Michigan bills to help farmers remain stalled, and a Kentucky industry founder warns the changes could threaten full-spectrum CBD oil. Congress faces competing interests ahead of a December deadline. CBD Investment: Olympic taekwondo champion Jade Jones is investing millions in a CBD wellness company, a high-profile bet on the sector. Consumer Guidance: A new guide urges shoppers to read CBD labels carefully and look beyond marketing claims.

Hemp Rules: Looming federal restrictions and THC caps have hemp retailers warning of risks to full-spectrum CBD products, jobs and sales. Product Lawsuits: Consumers are pressing ahead with a suit alleging delta-8 vape pens were mislabeled as legal hemp, keeping product claims and testing in focus. Retail Growth: Rhode Island approved longer delivery hours for dispensaries, while Cheech & Chong opened their first California shop in Forestville. Market Tensions: The cannabis-drink boom is sharpening competition with alcohol companies as lawmakers debate THC beverage restrictions. Virginia Fallout: Federal charges against Sen. Louise Lucas allege she used her influence to benefit a cannabis business, intensifying scrutiny of licensing ahead of Virginia’s planned 2027 retail market. Ballot Stakes: Massachusetts voters will decide whether to repeal recreational sales; recent polls indicate repeal is unpopular.

Workplace Lawsuit: A former Green Thumb employee in Illinois alleges she was fired because of an allergy to a cannabis strain; the company has not been found liable. Federal Policy: Hemp-derived THC drinks face a Dec. 11 ban unless Congress acts, putting a reported $1.5 billion market at risk. A Kentucky cannabis founder also warns federal hemp changes could threaten full-spectrum CBD oil. Industry & Politics: Virginia Sen. Louise Lucas and six others were indicted in an alleged cannabis distribution and corruption scheme; the charges remain allegations. Rescheduling: A DEA judge rejected a request to reopen the marijuana hearing, while allowing limited additional briefs. Market Outlook: Massachusetts voters will decide whether to repeal recreational cannabis sales, a move that would close the state’s legal adult-use industry.

Virginia Cannabis Probe: Federal prosecutors charged Sen. Louise Lucas and six others, alleging she used political influence to benefit an illegal marijuana enterprise. Lucas denies wrongdoing and says the case is politically motivated. Hemp Market Pressure: Looming federal THC restrictions threaten hemp-derived product sellers, including Michigan’s CBD industry. Businesses may keep existing stock but won’t be able to sell it once the ban takes effect; proposed relief for farmers remains stalled. Rescheduling Fight: A DEA judge rejected a request to reopen the marijuana rescheduling hearing, a setback for operators hoping rescheduling could bring tax relief. Kentucky Rollout: More than half of businesses licensed in Kentucky’s medical cannabis market are now open as the program expands statewide. Cannafest Showcase: Pet supplement brand Novohope plans to present dissolvable oral films and tablets at the Prague trade show in November, courting European distributors.

Virginia Cannabis Probe: Federal prosecutors indicted state Sen. Louise Lucas and six others, alleging she used her influence to protect a marijuana operation and launder its proceeds. Lucas denies wrongdoing and says she will fight the charges. Hemp Court Fight: A Sixth Circuit panel questioned whether Ohio can reclassify federally legal hemp products as marijuana, raising concerns for out-of-state sellers. Hemp Market: An approaching federal THC ban is prompting shipping-policy changes and uncertainty for hemp and CBD businesses. Hemp sellers may keep existing stock, but won’t be able to sell it once the ban takes effect. Cannabinoid Research: NeuroThera has cleared a manufacturing milestone for its cannabinoid-based Tourette syndrome treatment, paving the way for patient enrollment in a Phase IIb trial.

Hemp Rules: Federal restrictions could leave hemp businesses holding stock they can no longer sell, though they won’t have to destroy it. UPS is also tightening shipping requirements from Dec. 11, including lab-test documentation, adult signatures and a ban on aerosolized hemp products. CBD Market Risk: A Kentucky cannabis company founder warned the changes could threaten full-spectrum CBD oil, while Michigan’s CBD industry faces stalled efforts to help farmers adapt. Cannabis Deal Fight: Aurora urged shareholders to reject Curaleaf’s revised hostile takeover bid, saying it undervalues the company; Curaleaf says Aurora’s board is blocking a better offer. Testing and Safety: A Colorado audit found gaps in regulators’ oversight of cannabis product testing, renewing concerns about contamination and consumer protections. Policy and Voters: A new poll found 78% of cannabis consumers say candidates’ views on cannabis policy will influence their midterm vote.

Federal Hemp Rules: Proposed THC limits due in December threaten CBD products containing trace THC, including full-spectrum oils, while Michigan growers still face high compliance costs and stalled state relief. Industry advocates warn the changes could affect 80% to 95% of today’s CBD market, though that is their estimate, not a verified forecast. CBD Investment: York-based HempWell secured a multi-million-pound investment from Jade Jones and Richard Groves’ JJ Double Gold. The funding will support a new manufacturing facility, greater production capacity and a gummy line, with the partners targeting a £10 million valuation by 2029.

Hemp Rules: Looming federal THC limits are raising alarms for hemp and CBD businesses. A Kentucky company founder warns the changes could threaten full-spectrum CBD oil, while industry advocates say the proposals put jobs and sales at risk ahead of a December deadline. Product Safety: A Colorado audit found gaps in marijuana product testing rules, renewing questions about how regulators protect consumers. CBD Investment: An Olympic gold medalist is making a multimillion-pound investment in a CBD wellness company. Hemp Manufacturing: Renaissance Fiber secured $2.24 million to scale U.S. hemp-fiber production.

Hemp-THC Rules: Looming federal THC limits could put Georgia hemp shops at risk, with a separate report warning of up to $1 billion in state sales at stake. A Kentucky cannabis company founder says the changes could also threaten full-spectrum CBD oil. CBD Investment: Olympic gold medallist Jade Jones is investing millions in a CBD wellness company, while HighMoon Wellness is bringing nano-technology CBD recovery products to Florida. Industry Finance: Safe Harbor Financial won another 180 days to meet Nasdaq’s minimum share-price requirement. Hemp fiber maker Renaissance Fiber secured $2.24 million to expand U.S. manufacturing. Business Risks: A hemp payroll op-ed says Square’s removal of hemp and CBD products may foreshadow a bigger threat: payroll providers dropping businesses with little notice.

CBD Investment: Olympic champion Jade Jones’s JJ Double Gold has taken an equity stake in York-based HempWell, with a multi-million-pound investment planned over three years to support the CBD wellness company’s expansion. Hemp Regulation: A federal THC cap due to take effect Dec. 11 could put most hemp-derived edibles and drinks at risk. Industry estimates suggest 90% to 95% of consumable hemp products could lose legal status, threatening up to $1 billion in Georgia sales and hundreds of thousands of jobs nationwide.

CBD Business: York-based HempWell has agreed to a phased, multimillion-pound investment from JJ Double Gold, targeting a tenfold expansion and a £10 million valuation by 2029. Plans include a new manufacturing facility and a gummy production line, alongside growth beyond CBD into wellness and sports recovery. Licensing Fight: A federal court order keeps Jersey City’s The Cannabis Place dispensary open and requires the city council to put its license renewal to a vote. The company is challenging state-mandated labor agreements, arguing they conflict with federal law. Product Safety: Medicinal Genomics has launched next-day pathogen testing for supplements, using methods developed for cannabis labs to test products including gummies, powders and liquids. Contract Rights: NORML is urging the Sixth Circuit to reconsider a ruling that blocked enforcement of a cannabis company’s contract, warning the decision could weaken accountability in state-regulated markets.

Federal Policy: Marijuana rescheduling faces another delay, keeping tax relief uncertain for U.S. operators. Hemp businesses also face a looming federal THC ban, with small firms warning that compliance and insurance remain unsettled. State Rules: Kentucky’s medical dispensaries are now open across every licensing region, while a new Missouri study finds legal sales thriving and points to competition as the next challenge. Florida debate is turning to whether hemp-derived THC drinks should be regulated rather than prohibited; Kentucky businesses are also pressing lawmakers to lower hemp licensing fees. Hemp Market Strain: Tennessee’s hemp sector is still reeling from a new law, with shops closing and beverage makers bracing for lost sales. Product Safety: Maine issued a patient advisory over contaminated cannabis flower and pre-rolls, underscoring the importance of quality controls as regulated markets expand.

Federal Policy: Cannabis rescheduling has hit another delay as opponents seek to add a GAO report and other material to the review. The setback prolongs uncertainty for operators such as Green Thumb, which could benefit from relief from federal tax restrictions. State Markets: Massachusetts dispensaries are campaigning against a November ballot measure that would end recreational sales in 2028 while preserving medical access. Missouri’s first market study finds legal sales thriving, with competition emerging as a key issue. Hemp Rules: Businesses are bracing for new federal hemp restrictions set to take effect Dec. 11, with small operators warning the transition is creating uncertainty. Medical Cannabis: Morocco approved three cannabis-based epilepsy drugs, while Kentucky says medical dispensaries are now open in every region of the state.